From April 1, 2022 to April 12, 2022, the company has repurchased 6,907,500 shares, representing 0.45% for ¥24,992.96 million. With this, the company has completed the repurchase of 29,376,900 shares, representing 1.88% for ¥99,965.66 million under the buyback announced on October 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,089 JPY | -0.02% | +0.49% | +0.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.86% | 41.26B | |
+26.10% | 653B | |
+26.72% | 556B | |
-6.48% | 354B | |
+20.53% | 331B | |
+5.68% | 296B | |
+12.77% | 233B | |
+5.53% | 201B | |
-9.53% | 193B | |
-5.89% | 144B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced on October 28, 2021.